Barr Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of generic and proprietary pharmaceuticals. Its generic product portfolio includes solid oral dosage forms, injectables, and cream/ointment products. Barr Pharmaceuticals’ proprietary product portfolio and pipeline is concentrated in the area of female healthcare. As of December 31, 2006, the company marketed approximately 245 different dosage forms and strengths of approximately 115 different generic pharmaceutical products, including 24 oral contraceptive products in the United States; and 320 different molecules, representing 1,250 generic pharmaceutical products in approximately 3,120 different...